KAINOS Laboratories, Inc. (TYO:4556)
Japan
· Delayed Price · Currency is JPY 1,174.00
+39.00 (3.44%)
Apr 24, 2025, 3:30 PM JST
KAINOS Laboratories Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 |
|---|---|---|---|---|---|---|
Period Ending | Dec '10 Dec 31, 2010 | Mar '10 Mar 31, 2010 | Mar '09 Mar 31, 2009 | Mar '08 Mar 31, 2008 | Mar '07 Mar 31, 2007 | Mar '06 Mar 31, 2006 |
| Revenue | 4,437 | 4,215 | 3,595 | 3,960 | 4,100 | 4,589 |
| Revenue Growth (YoY) | 8.49% | 17.25% | -9.21% | -3.42% | -10.66% | - |
| Cost of Revenue | 2,885 | 2,695 | 2,313 | 2,584 | 2,658 | 2,909 |
| Gross Profit | 1,551 | 1,520 | 1,281 | 1,375 | 1,441 | 1,681 |
| Selling, General & Admin | 1,102 | 1,069 | 1,008 | 1,070 | 1,083 | 1,238 |
| Research & Development | 196.49 | 196.49 | 204.84 | 209.11 | 217.22 | 236.02 |
| Other Operating Expenses | 9.54 | 9.54 | 9.52 | 10.18 | 10.8 | 10.04 |
| Operating Expenses | 1,350 | 1,318 | 1,261 | 1,328 | 1,354 | 1,517 |
| Operating Income | 200.97 | 201.81 | 20.77 | 47.45 | 87.57 | 164.07 |
| Interest Expense | -28.57 | -32.3 | -37.37 | -35.92 | -29.36 | -25.23 |
| Interest & Investment Income | 7.97 | 7.72 | 10.01 | 9.11 | 6.98 | 6.52 |
| Currency Exchange Gain (Loss) | 1.49 | -4.36 | 3.23 | 6.39 | 3.57 | -3.05 |
| Other Non Operating Income (Expenses) | 12.09 | 11.08 | 9.81 | 6.54 | 7.27 | 0.24 |
| EBT Excluding Unusual Items | 193.95 | 183.95 | 6.44 | 33.57 | 76.03 | 142.55 |
| Merger & Restructuring Charges | - | - | - | - | -4.58 | -29.3 |
| Gain (Loss) on Sale of Investments | -47.21 | 0.01 | 418.23 | - | 0.37 | 435.27 |
| Gain (Loss) on Sale of Assets | 0.15 | - | -124.18 | - | - | -64.24 |
| Asset Writedown | -12.75 | -7.69 | -8.98 | - | -0.95 | - |
| Other Unusual Items | -3.6 | - | - | -0.12 | -25.87 | -28.94 |
| Pretax Income | 133.59 | 179.32 | 291.51 | 33.45 | 44.99 | 455.35 |
| Income Tax Expense | 50.83 | 77.88 | 123.79 | 29.3 | 29.88 | 224.4 |
| Net Income | 82.76 | 101.44 | 167.72 | 4.15 | 15.1 | 230.95 |
| Net Income to Common | 82.76 | 101.44 | 167.72 | 4.15 | 15.1 | 230.95 |
| Net Income Growth | -19.14% | -39.52% | 3940.45% | -72.52% | -93.46% | - |
| Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | 4 |
| Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | 4 |
| Shares Change (YoY) | -0.03% | -0.03% | -0.04% | -0.03% | -0.03% | - |
| EPS (Basic) | 18.58 | 22.77 | 37.64 | 0.93 | 3.39 | 51.78 |
| EPS (Diluted) | 18.58 | 22.77 | 37.64 | 0.93 | 3.39 | 51.78 |
| EPS Growth | -19.11% | -39.50% | 3942.10% | -72.51% | -93.46% | - |
| Free Cash Flow | 197.85 | 99.68 | 173.35 | 183.32 | -365.56 | -119.17 |
| Free Cash Flow Per Share | 44.43 | 22.38 | 38.91 | 41.13 | -81.99 | -26.72 |
| Dividend Per Share | 7.500 | 7.500 | 4.000 | - | 7.500 | 7.500 |
| Dividend Growth | 87.50% | 87.50% | - | - | - | - |
| Gross Margin | 34.97% | 36.06% | 35.65% | 34.73% | 35.16% | 36.62% |
| Operating Margin | 4.53% | 4.79% | 0.58% | 1.20% | 2.14% | 3.57% |
| Profit Margin | 1.86% | 2.41% | 4.67% | 0.10% | 0.37% | 5.03% |
| Free Cash Flow Margin | 4.46% | 2.37% | 4.82% | 4.63% | -8.92% | -2.60% |
| EBITDA | 311.32 | 298.49 | 150.48 | 156.66 | 197.1 | 239.84 |
| EBITDA Margin | 7.02% | 7.08% | 4.19% | 3.96% | 4.81% | 5.23% |
| D&A For EBITDA | 110.35 | 96.68 | 129.71 | 109.21 | 109.53 | 75.77 |
| EBIT | 200.97 | 201.81 | 20.77 | 47.45 | 87.57 | 164.07 |
| EBIT Margin | 4.53% | 4.79% | 0.58% | 1.20% | 2.14% | 3.57% |
| Effective Tax Rate | 38.05% | 43.43% | 42.47% | 87.59% | 66.43% | 49.28% |
| Revenue as Reported | 4,215 | 4,215 | 3,595 | 3,960 | 4,100 | 4,589 |
| Advertising Expenses | - | 47.87 | 37.02 | 36.71 | 46.44 | 117.09 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.